Metrasens Acquires New Patents to Further Protect Its Innovative Technology

Share Article

Metrasens, a leading provider of advanced magnetic detection technologies, announced today that as part of its ongoing strategy of continual innovation and intellectual property protection it has now taken assignment of a number of patents from QinetiQ Limited.

Metrasens Ferroguard FMDS for MRI Safety

Metrasens Ferroguard FMDS for MRI Safety

"Our portfolio of patents continues to grow worldwide, extending the protection of our core technology across an increasingly wide range of applications from use in MRI Safety and Corrections facilities to Mental Health Security and most recently Counterterrorism."

In the last four months it has also obtained grant of its own patents in USA and Europe in two core families and allowance of six more in USA, China and Japan from three other patent families covering the magnetic detection platform which is at the heart of its MRI safety and security products.

The patents assigned from QinetiQ include US 7113092, titled “Ferromagnetic Object Detector” which relates to the use of magnetic with non-magnetic sensors to detect ferromagnetic objects for MRI Safety and for a range of security applications.

The recently granted patents (US 9514624 and EP2606387, US9995713 and EP2725973) cover features designed to optimize usability in MRI safety applications, and the use of a separate pre-screening device, which is also at the heart of Metrasens security systems.

These patents add to Metrasens’ growing reputation for innovation directed at helping to make the world a safer place. The company was recently awarded the Queen’s Award for Enterprise, the UK’s most prestigious business award, in the category of Innovation.

Commenting on these latest patent successes, Dr. Simon Goodyear, Metrasens’ CEO said: “2018 has been a year of continued growth for Metrasens and the recent grant and allowance of these patents is a demonstration of the strength of our technology that underpins this business success.”

“As an innovative technology company our intellectual property is very important to us. Our portfolio of patents continues to grow worldwide, extending the protection of our core technology across an increasingly wide range of applications from use in MRI Safety and Corrections facilities to Mental Health Security and most recently Counterterrorism. We currently have many other patent applications in progress as we continue to extend our intellectual property and are now well placed to start to enforce it too. Our position will only grow stronger over the coming months and years.”

For more information about Metrasens, visit http://www.metrasens.com.

Share article on social media or email:

View article via:

Pdf Print

Contact Author

Colin Robertson
Metrasens
+44 07585 212026
Email >
@metrasens
Follow >
Visit website